Corrigendum to “Classic and atypical late infantile neuronal ceroid lipofuscinosis in Latin America: Clinical and genetic aspects, and treatment outcome with cerliponase alfa.” [Molecular Genetics and Metabolism ReportsVolume 38 (2024) 101060]
Saved in:
Similar Items
-
Evaluation of Visual Pathways in Children with Neuronal Ceroid Lipofuscinosis: Diffusion Tensor Imaging Findings
by: Hafize Otcu Temur, et al.
Published: (2024-09-01) -
Neuronal Ceroid Lipofuscinosis in Border Collie Dogs in Japan: Clinical and Molecular Epidemiological Study (2000–2011)
by: Keijiro Mizukami, et al.
Published: (2012-01-01) -
Cone‐Rod Dystrophy and Progressive Visual Loss as the First Manifestation of Neuronal Ceroid Lipofuscinosis Type 7: A Case Report
by: Seyedeh Maryam Hosseini, et al.
Published: (2024-11-01) -
Adverse Reactions to the Orphan Drug Cerliponase Alfa in the Treatment of Neurolipofuscinosis Type 2 (CLN2)
by: Ilaria Ammendolia, et al.
Published: (2024-11-01) -
Efecto de las construcciones en el medio paisajístico de Puerto Santa Ana, provincia Del Guayas
by: Martha Arteaga, et al.
Published: (2017-06-01)